Tumor CD8 T cells monitoring [Supplementary Figure 3D] revealed early differences on Day 2 between the FD Cisplatin group and both the FD Pemetrexed and LD Cisplatin groups (P < 0.01 and P = 0.05, respectively). Here, CD8A is linked to neoplasm.